Actively Recruiting

Phase Not Applicable
Age: 15Years - 24Years
All Genders
ID04889911

Development of a Stage-specific Adaptation of a Self-stigma Intervention for People Recovering from a First Episode of Psychosis

Led by John Jay College of Criminal Justice, City University of New York · Updated on 2025-03-24

40

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

J

John Jay College of Criminal Justice, City University of New York

Lead Sponsor

I

Indiana University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating a modified psychosocial intervention called Narrative Enhancement and Cognitive Therapy for Young Adults (NECT-YA) in youth aged 15 to 24 who have experienced a first episode of psychosis (FEP). This study aims to adapt NECT to better meet the needs of young people with FEP, focusing on self-concept and illness beliefs to improve treatment engagement. The research compares NECT-YA combined with Coordinated Specialty Care (CSC) to CSC alone in a small randomized controlled trial with 40 participants. NECT-YA is a structured treatment originally consisting of 20 group sessions combining psychoeducation, cognitive restructuring, and narrative psychotherapy. For this study, it may be shortened, delivered individually, or via telehealth to suit youth with FEP. Both study groups receive CSC, an evidence-based, multi-component treatment for FEP. The trial will assess how well participants accept and complete the modified NECT alongside CSC services. Participants will undergo assessments measuring treatment engagement, therapeutic alliance, coping with symptoms, self-esteem, hopelessness, and social functioning. Researchers will also gather qualitative feedback on NECT-YA to refine the intervention. The study includes baseline and follow-up evaluations to monitor these outcomes, providing insights into the intervention's feasibility and effects over time.

CONDITIONS

Brief Title

Pilot RCT of Self-stigma Treatment for First Episode Psychosis

Who Can Participate

Age: 15Years - 24Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 15 to 24 years
  • Experienced onset of psychotic symptoms within the last 5 years
  • Does not have a primary substance use or mood disorder causing the psychotic symptoms
  • Has moderate or elevated self-stigma based on the Internalized Stigma of Mental Illness Scale
  • Speaks English well enough to complete assessments and participate in groups
  • Able to provide informed consent to participate
Not Eligible

You will not qualify if you...

  • Does not meet the above inclusion criteria

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Outpatient Treatment

Duration - Duration of the 20-session treatment program

Participants receive a structured, 20-session behavioral intervention called NECT-YA, combined with Coordinated Specialty Care, or Coordinated Specialty Care alone, tailored for individuals recovering from a first episode of psychosis.

Up to 20 sessions delivered in group, individual, or telehealth format

Trial Site Locations

Total: 1 location

1

Eskenazi Health, PARC Program

Indianapolis, Indiana, United States, 46202

Actively Recruiting

Loading map...

Research Team

B

Bethany Leonhardt, Psy.D.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Early-phase Schizophrenia: Practice-based Research to Improv...

First Episode Psychosis

Actively Recruiting

5 locations

Digital Strategies to Advance Help-Seeking in Youth at Clini...

Clinical High Risk

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here